Palisade Bio's market cap is currently $199.45M. The company's EPS TTM is $-0.581; its P/E ratio is -0.29; Palisade Bio is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
